In vivo detection of short‐ and long‐term MDMA neurotoxicity—a positron emission tomography study in the living baboon brain
暂无分享,去创建一个
Z. Szabo | R. Dannals | H. Ravert | G. Ricaurte | U. Scheffel | R F Dannals | U Scheffel | H T Ravert | P A Finley | W B Mathews | Z Szabo | K Szabo | J Yuan | G A Ricaurte | Jie Yuan | P. Finley | William B. Mathews | Hayden T. Ravert | Katalina Szabo | George A. Ricaurte
[1] R. Dannals,et al. Synthesis of a radiotracer for studying serotonin uptake sites with positron emission tomography : [11C]McN-5652-Z , 1992 .
[2] H N Wagner,et al. A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] C. Halldin,et al. Pet study of [11C] β‐CIT binding to monoamine transporters in the monkey and human brain , 1994, Synapse.
[4] C. J. Schmidt,et al. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.
[5] D. Mash,et al. Visualizing Dopamine and Serotonin Transporters in the Human Brain with the Potent Cocaine Analogue [125I]RTI‐55: In Vitro Binding and Autoradiographic Characterization , 1994, Journal of neurochemistry.
[6] Y. Claustre,et al. Characterization of [3H]paroxetine binding to rat cortical membranes. , 1985, European journal of pharmacology.
[7] G. Ricaurte,et al. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] H N Wagner,et al. Positron Emission Tomography of 5-HT Transporter Sites in the Baboon Brain with [11C]McN5652 , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] Marc Laruelle,et al. SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates , 1993, Synapse.
[10] R. Shank,et al. Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships. , 1987, Journal of medicinal chemistry.
[11] J. Langston,et al. Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration , 1988, Brain Research.
[12] C. Mathis,et al. [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hyfroxytryptamine uptake complex. I. In vitro studies , 1993, Brain Research.
[13] E. D. De Souza,et al. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. , 1987, Journal of Pharmacology and Experimental Therapeutics.
[14] M Laruelle,et al. Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT. , 1991, European journal of pharmacology.
[15] J. M. Ollinger,et al. Positron Emission Tomography , 2018, Handbook of Small Animal Imaging.
[16] W. Jagust,et al. In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine. , 1993, European journal of pharmacology.
[17] K. Någren,et al. PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] H N Wagner,et al. [11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET. , 1993, Life sciences.
[19] F I Carroll,et al. In vivo binding of [125I] RTI‐55 to dopamine transporters: Pharmacology and regional distribution with autoradiography , 1992, Synapse.
[20] C. Mathis,et al. [125I]5-iodo-6-nitro-2-piperazinylquinoline: a potent and selective ligand for the serotonin uptake complex. , 1992, European journal of pharmacology.
[21] M. Wilson,et al. (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. , 1988, JAMA.
[22] P S Goldman-Rakic,et al. Quantitative autoradiographic mapping of serotonin 5‐HT1 and 5‐HT2 receptors and uptake sites in the neocortex of the rhesus monkey , 1989, The Journal of comparative neurology.
[23] Zsolt Szabo,et al. Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652 , 1995, Synapse.
[24] E. D. De Souza,et al. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4‐methylenedioxymethamphetamine): Assessment using quantitative autoradiography , 1991, Synapse.
[25] M. Kuhar,et al. Development of PET/SPECT ligands for the serotonin transporter. , 1994, NIDA research monograph.
[26] M. Kaufman,et al. Distribution of cocaine recognition sites in monkey brain: II. Ex vivo autoradiography with [3H]CFT and [125I]RTI‐55 , 1992, Synapse.
[27] E. London,et al. Synthesis of a radiotracer for studying nicotinic acetylcholine receptors : (+/−)-exo-2-(2-[18F]fluoro-5-pyridyl)-7-azabicyclo[2.2.1]heptane , 1996 .
[28] M. Kuhar,et al. Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: In vivo studies with [125i]rti‐55 , 1994, Synapse.
[29] M. Kuhar,et al. [123/125I]RTI‐55, an in vivo label for the serotonin transporter , 1992, Synapse.
[30] S. Snyder,et al. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. , 1987, The Journal of pharmacology and experimental therapeutics.
[31] Robert B. Innis,et al. Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[32] C. Halldin,et al. [11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations. , 1993, Nuclear medicine and biology.
[33] F I Carroll,et al. High‐affinity binding of [125I]RTI‐55 to dopamine and serotonin transporters in rat brain , 1992, Synapse.
[34] G. Knoll,et al. Single-photon emission computed tomography , 1983, Proceedings of the IEEE.
[35] T. Insel,et al. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys. , 1989, The Journal of pharmacology and experimental therapeutics.
[36] R. Shank,et al. McN-5652: a highly potent inhibitor of serotonin uptake. , 1988, The Journal of pharmacology and experimental therapeutics.
[37] W. Jagust,et al. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] G. Ricaurte,et al. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. , 1992, The Journal of pharmacology and experimental therapeutics.
[39] G. Hanson,et al. Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat , 1987, Neuropharmacology.
[40] Alan A. Wilson,et al. Synthesis of a radiotracer for studying dopamine uptake sites in vivo using PET: 2β‐carbomethoxy‐3β‐(4‐fluorophenyl)‐[N‐11C‐methyl]tropane ([11C]CFT or [11C]WIN‐35,428) , 1993 .
[41] L S Seiden,et al. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. , 1987, The Journal of pharmacology and experimental therapeutics.